Minoryx Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 27
Employees
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $29.4M
Latest Deal Amount
  • Investors
  • 18

Minoryx General Information

Description

Developer of therapies designed to provide innovative treatments for life-threatening rare diseases. The company's therapies focus on a group of diseases of genetic origin with high unmet medical needs and discover a new generation of pharmacological chaperones to restore protein functionality, thereby enabling patients to be relieved from the suffering of orphan diseases.

Contact Information

Website
www.minoryx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • TecnoCampus Mataró-Maresme 3
  • Avenida Ernest Lluch 32
  • 08302 Barcelona
  • Spain
+34 935 00 00 00

Minoryx Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Minoryx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Debt - General 30-Oct-2020 $29.4M 000.00 Completed Generating Revenue
10. Later Stage VC 15-Aug-2020 000.00 000.00 Completed Generating Revenue
9. Later Stage VC (Series B) 26-Sep-2018 000.00 000.00 Completed Generating Revenue
8. Grant 09-Apr-2018 00.000 000.00 Completed Generating Revenue
7. Later Stage VC 00.000 000.00 Completed Generating Revenue
6. Early Stage VC 04-Sep-2015 00000 000.00 Completed Generating Revenue
5. Early Stage VC (Series A) 28-Jul-2015 000.00 000.00 Completed Generating Revenue
4. Seed Round 23-Dec-2014 00.000 00.000 Completed Generating Revenue
3. Grant 06-Dec-2013 $6.76K $2.07M Completed Generating Revenue
2. Seed Round 02-Apr-2013 $2.07M $2.07M Completed Generating Revenue
To view Minoryx’s complete valuation and funding history, request access »

Minoryx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapies designed to provide innovative treatments for life-threatening rare diseases. The company's thera
Drug Discovery
Barcelona, Spain
27 As of 2020
000.00
000000000 000.00

00000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua
0000000000000
Tucson, AZ
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

00000000

a pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt molli
0000000000000
San Francisco, CA
000 As of 0000
00000
0.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Minoryx Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Calimmune Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
00000000 000000000 Formerly VC-backed San Francisco, CA 000 00000 000000&0 00000
00000000 0000 0000 Formerly VC-backed Bannockburn, IL 0000 00000 000000&0 00000
00000 Venture Capital-Backed Cambridge, MA 0 0000 0000000000 0 0000
00000 Formerly VC-backed Boston, MA 00 00000 00000000 00000
You’re viewing 5 of 31 competitors. Get the full list »

Minoryx Executive Team (10)

Name Title Board Seat Contact Info
Marc Martinell Ph.D Co-Founder, Chief Executive Officer & Board Member
Sonia Poli Ph.D Chief Scientific Officer
Sílvia Pascual Director, Clinical Operations
Maria Pascual Ph.D Chief Regulatory Officer
Joan Aymamí Co-Founder and Scientific Advisor
You’re viewing 5 of 10 executive team members. Get the full list »

Minoryx Board Members (19)

Name Representing Role Since
Claude Nicaise MD Self Board Member 000 0000
Géry Lefebvre Société Régionale d'Investissement de Wallonie Board Member 000 0000
Karen Wagner Ysios Capital Board Member 000 0000
Khalid Islam Ph.D Self Chairman 000 0000
Marc Martinell Ph.D Minoryx Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Minoryx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Minoryx Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Federal Holding and Investment Company Holding Company Minority 000 0000 000000 0
Fund+ Venture Capital Minority 000 0000 000000 0
SambrInvest Venture Capital Minority 000 0000 000000 0
Société Régionale d'Investissement de Wallonie Growth/Expansion Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »